View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The study “Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom” used the Small Animal Veterinary Surveillance Network to review electronic health records equating to 3,150,713 consultations (917,373 dogs) from 224 veterinary practices2.
Five hundred and seventeen cases were included. Dogs older than 6 years were excluded.
Of 321 dogs presented for a single seizure, seven (2.1%) were prescribed AEDs, which is in accordance with International Veterinary Epilepsy Task Force recommendations.
20% of the dogs in this group which had at least a 6-month follow-up, 20% did not have subsequent seizures recorded.
However, of 86 dogs which had suffered a seizure cluster at first presentation, only 38 (44%) were prescribe an AED, despite the task force recommendation that long term treatment in dogs with idiopathic epilepsy should be started immediately in the case of 2 or more seizures within 6 months, status epilepticus or a seizure cluster, severe post-ictal signs, or a deteriorating epileptic presentation.
Imepitoin was frequently selected in the treatment of cluster seizures despite no authorisation for this purpose.
Nicola Di Girolamo, Editor of JSAP said: “Studies like this one are instrumental to understand how primary care clinicians comply with current recommendations.
"Additional efforts may be required to fully adhere to the International Veterinary Epilepsy Task Force recommendations; being aware of these gaps is the first step towards improvement.”
References
The hearing proceeded in Ms Kay’s absence as she failed to attend. The Committee heard a number of charges relating to her practising while under the influence of alcohol, breaching undertakings to the College to abstain completely from alcohol, alleged serious clinical failings in relation to the treatment of two dogs, Izzy and Alfie, and making disparaging remarks to a client about other veterinary surgeons (the complete list of charges can be found on the College’s website: www.rcvs.org.uk/concerns/disciplinary-hearings/).
In relation to the first charge, (that in September 2016, while a locum veterinary surgeon at Haven Veterinary Surgeons Group, Great Yarmouth, she was under the influence of alcohol), the Committee heard from a veterinary nurse at the practice who told how on different occasions Miss Kay had appeared to need more assistance than expected, was overly friendly in speaking to clients, was unable to prepare a syringe correctly, and finally, on 14 September 2016, was found asleep in the car with an open can of alcohol by her feet. The Committee also heard from a number of other witnesses from the Haven Veterinary Surgeons Group who also provided evidence of Ms Kay’s behaviour on the day in question. Following deliberations, the Committee found the first charge to be proved.
The second charge related to the breaching of undertakings which Ms Kay had given to the College to the effect that she would abstain completely from alcohol. When samples were taken on 3 August 2017, however, it was found that she had been consuming alcohol in the recent past. The Committee was therefore satisfied that the second charge was proved.
The Committee then turned to the third charge, that in March 2017 Ms Kay had displayed a number of clinical failings when performing surgery on a cocker spaniel, Izzy, belonging to Mrs Debbie Coe. The Committee found the majority of the charges proved, amongst others that she failed to obtain informed consent for surgery, performed surgery in her own home when it was not registered as a veterinary practice and it was not possible to ensure sterility, and that she failed to provide suitable post-operative analgesia to Izzy.
The College then turned to the fourth charge, which concerned her treatment of Mrs Coe’s other dog, Alfie, a Miniature Schnauzer. The charge was that in March 2017, Ms Kay euthanased Alfie in an inappropriate manner, and used a controlled drug without having a registered veterinary premise from which to dispense it. After hearing from an expert witness the Committee found the charges proved.
Finally, the Committee heard evidence relating to the fifth charge, namely that in or around July 2016, Ms Kay made disparaging remarks to Mrs Coe about other veterinary surgeons who had treated Alfie, and that between 17 March and 31 March 2017 she had sent inappropriate texts and voicemail messages to Mrs Coe about the treatment of her dogs and payments owed in relation to this. The Committee thought there was not enough evidence in relation to the voicemails, but found the remainder of the charge proved.
Taking all into account, the Committee found that Ms Kay’s conduct had fallen far short of the standard expected of a member of the veterinary profession and concluded that her conduct clearly amounts to disgraceful conduct in a professional respect.
Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee considered that the only appropriate sanction is that of removal from the Register. Such a sanction is required to protect animals and to send a clear message to the Respondent, and to all veterinary surgeons, of the unacceptability of the conduct identified in this case. Such conduct undermines public confidence in the profession and fails to uphold proper standards of conduct and behaviour.
"Accordingly, the Committee has decided that removal from the Register is the only appropriate and proportionate sanction in this case."
Ms Kay has 28 days from being informed about the Disciplinary Committee’s decision to make an appeal to the Privy Council.
Suvaxyn PRRS MLV offers the earliest piglet vaccination from the first day of age, securing immunity before the risk period which lasts until the end of the fattening. Pig protection is established 28 days after vaccination, and lasts for 26 weeks after vaccination in fattening pigs, and 16 weeks after vaccination in gilts and sows. Zoetis says the vaccine reduces viremia and nasal shedding of the virus.
Monica Balasch, Associate Director, Global Biologicals Development at Zoetis said: "In Europe, Porcine Reproductive and Respiratory Syndrome is known for severe impacts on reproduction including lowering birth rates, increasing abortion, stillbirth, mummified, as well as weak live-born piglets, and death.
"In clinical studies conducted with Suvaxyn PRRS MLV, we found excellent results vaccinating pigs from the first day of age. It is safe to be used as the earliest protection in piglets, and to protect the whole herd against PRRS, as it is also safe for use in gilts and sows.
"The new vaccine represents a flexible alternative to allow for new customized PRRS control programs developed by veterinarians for producers."
Alvaro Aldaz, Director, Commercial Development and Innovation, Swine, at Zoetis said: "We are excited to bring this innovative vaccine to Europe. Suvaxyn PRRS MLV has been developed using a very innovative vaccine technology which brings swine veterinarians a new advanced PRRS control tool.
"As well reducing viremia, nasal shedding and lung lesions in fattening pigs, the vaccine has been proven to overcome maternal immunity, which increases the efficacy of the vaccine when given to piglets during the first days of life. Additionally, it allows veterinarians for use PRRS mass vaccination within the claim; mass vaccination has become more and more popular in several European countries."
Suvaxyn PRRS MLV is a veterinary vaccine that contains a European PRRS virus strain (Genotype 1) that has been grown and attenuated in a uniquely modified cell line developed by Zoetis.
Jay Calvert, Research Director, VMRD Global Biologicals Research at Zoetis said: "Suvaxyn PRRS MLV is safe based on true loss of virulence, and not based on a temporary reduction in ability to replicate in macrophage cells in the lung of the pig."
Zoetis says the efficacy of Suvaxyn PRRS MLV is supported by a comprehensive program of clinical studies reviewed by the European Medicines Agency and included in the regulatory procedure approved by the European Commission in August 2017.
The European public assessment report is available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/veterinary/004276/WC500235212.pdf
The company says the most common side effects with Suvaxyn PRRS MLV (which may affect more than one in 10 pigs) are a short-lived increase in body temperature (0.5°C on average and up to 1.4°C individually) within four days of vaccination, and in sows local reactions in the form of swellings which resolve without treatment within five to 32 days.
Prilactone Next is replacing the spironolactone products Prilactone and Tempora, which will be discontinued.
Prilactone Next is available in three presentations of 10mg, 50mg and 100mg. It comes in easy-break, chewable tablets, designed to make it easier to give the required dose. The 10mg tablet has a two-way split for a dog between 2.5kg and 5kg, while the 50mg and 100mg tablets have a four-way patented clover-shaped design with the 50mg for dogs between 18.1kg and 25kg and 100mg for dogs between 37.6kg and 50kg.
Prilactone Next is available in boxes of three blisters of 10 tablets for the 10mg and 50mg presentations and three blisters of eight tablets for the 100mg presentation, for easy dispensing and storage in practice.
Nicola Barclay, product manager at Ceva Animal Health, said: "Prilactone Next is an improved, easy to administer spironolactone that enables owners to accurately treat their pets and will further enhance our existing cardiology range."
For further information, contact your local Ceva Animal Health territory manager.
The new maternity policy will offer enhancement at 100% of full pay for 10 weeks, and 50% of full pay for a further 10 weeks, without any clawback provision should mothers decide not to return to CVS after their leave.
As part of the Time To Change Pledge, CVS will submit a plan for introducing evidence-based interventions and policy to help its employees work in ways that promote positive mental wellbeing.
CVS's plan includes the appointment of 250 Wellbeing Champions who will be trained in first aid for mental health. The company also plans to roll out further training on managing stress and mental health issues for line managers in 2020.
Richard, pictured right, said: "We are proud to be the first major veterinary employer to sign the Time to Change Pledge. The CVS wellbeing working party have made much progress in the last 12 months delivering our plan which has been formalised through participating in the Time to Change pledge.
"We recognise that the pressures in our industry are significant and unique, and that there’s more work to do. We remain committed as a company and wellbeing working party to changing the way we all think and act about mental health in the workplace for the better."
The centre was launched in February last year after an 8-month briefing and design period, followed by a 9-month construction and fit-out process.
Paragon and DesM also picked up the top prize in the Conversion category, awarded to practices which have made use of buildings previously used for other purposes.
John Marsh said: "Our aim was to build on our experience with two previous small animal hospitals for the RVC and Lower Langford Veterinary School, in designing a 'practitioners' answer' to veterinary care, but adapted to a more commercial facility, mindful of a practical but bright working environment for both the clinicians and owners, where it is a pleasure to work and a catalyst for enabling the best possible animal care."
Paragon managing director Ian Monteith said: "Every year, the BVHA seeks out and rewards the very best veterinary hospitals across the UK and we are delighted the high standards we set here at Paragon have been recognised.
"This is a terrific compliment to the very careful planning that went into designing the building and equipping it with the very latest equipment and technology."
In their report, the BVHA assessor said: "The premises are spectacular in design and appearance, creating an immediate impression of clinical excellence and quality patient care to both clients and visiting clinicians.
"The quality of the clinical work being undertaken was easy to see. There was a very positive attitude to training and induction routines, as well as mental health and team welfare."
There was one other category, for the best refurbishment, which was won by Vets Now’s hospital in Glasgow.
The individual, referred to as Mrs D throughout the hearing and who was granted anonymity by the Committee on grounds relating to her health, faced three charges against her.
The first charge was that she posted the tweets from her Twitter/X account.
The second charge was that in a number of tweets (Schedule 1 below), she falsely stated or implied that she was a veterinary surgeon, and that, in some tweets, while falsely holding herself out to be a veterinary surgeon, she used language that was offensive and/or unprofessional.
The third charge was that in a number of tweets (Schedule 2 below) she made statements that were offensive, discriminatory and brought the veterinary professions into disrepute.
At the outset of the hearing Mrs D admitted all the facts of the charges against her, and also admitted that her conduct amounted to disgraceful conduct in a professional capacity.
The Committee considered that there were a number of aggravating factors in Mrs D’s behaviour, including a lack of probity and integrity, as well as dishonesty, in holding herself out as a veterinary surgeon.
Her conduct was also premeditated and took place over a lengthy period of time, involved abuse of her position, and demonstrated discriminatory behaviour, as a large number of her tweets were highly offensive towards various minority groups.
In mitigation, the Committee heard from the respondent that she had a number of difficulties in her personal life which led to inappropriate use of social media, though she did not suggest these factors excused her behaviour.
The Committee also considered that Mrs D had a long and previously unblemished career of 15 or so years, had made early admissions (albeit she had initially denied being responsible for the tweets) and shown considerable remorse.
However, in terms of the sanction, the Committee considered that removal from the Register was the most proportionate sanction it could impose.
Paul Morris, who chaired the Committee and spoke on its behalf, said: “For a registered veterinary nurse to pretend to be a veterinary surgeon on a public platform is itself an extremely serious matter.
"When that presentation is associated with the highly offensive language of the tweets in this case, extending over a period of years, the conduct is in the view of the Committee fundamentally incompatible with continued registration.
“The Committee has concluded that removal from the register is the only sanction which is sufficient to satisfy the public interest in maintaining proper standards of behaviour for registered veterinary practitioners and public confidence in the profession and its regulation.”
www.rcvs.org.uk/disciplinary
The Tweets
Schedule 1
Schedule 2
Betafuse contains 5mg/g fusidic acid and 1mg/g betamethasone gel. It is available in 15g and 30g polyfoil tubes, designed to reduce the likelihood of splitting and loss of product during use.
Richard Palmer, Global Head of Sales and Marketing at Norbrook said: "We are delighted to be bringing this new product to the market in 16 European countries including the UK and Ireland. Betafuse is particularly exciting for us as we have improved the packaging and we have extended the 'in use' shelf life to eight weeks in comparison to six weeks for the pharmaceutically equivalent pioneer.
"This continued investment in our companion animal portfolio comes on the back of our recent launch in the US of Carprofen Chewable Tablets, an anti-inflammatory also for dogs. Our £40 million multi-year investment programme which we are currently engaged in, includes a significant emphasis on new product development including investment in R&D and our facilities infrastructure."
Lizzie Barnard, UK Product Manager added: "Betafuse offers the prescribing veterinary surgeon greater choice and it complements our existing companion animal skin care portfolio which includes Marbodex, a treatment for otitis externa in dogs.
"“Product support material is available and includes a guide for dog owners on how to apply Betafuse simply and effectively. This leaflet is available by contacting your territory manager or by downloading it from our website."
For more information, visit: https://www.norbrook.com/
Mr Wood was removed from the Register in 2018 after being convicted of posessing indecent images of children and made subject to a Sexual Harm Prevention Order for five years.
Mr Wood first applied to rejoin the Register in 2020 but his application was rejected.
At the outset of his second application last month, Mr Wood’s counsel argued that he is professionally competent to be restored, that he had strong mitigation for his offending, that he had consistently and repeatedly expressed and demonstrated profound remorse, that he posed a low risk of re-offending, that he had proactively engaged with the Probation Service and voluntary counselling to gain further insight into his offending, and that he had completed his community sentence and was no longer subject to any of the court orders arising from his conviction.
The Committee then weighed up whether Mr Wood had accepted its original findings in 2018, the seriousness of the offences, whether he demonstrated insight, protection of the public and the public interest, the future welfare of animals should he be restored to the Register, the length of time off the Register, Mr Wood's conduct since he was removed and evidence that he had kept up-to-date with veterinary knowledge, skills and practice.
Dr Kathryn Peaty MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee is satisfied that Mr Wood has done everything required of him in order to be able to satisfy the Committee that he is fit to be restored to the Register.
“At the last application in June 2020, he was unsuccessful largely because of the outstanding ancillary Court Orders that did not conclude until early 2023. Those Orders have now concluded
“He has shown significant insight into his offending behaviour. He has been proactive in his rehabilitation and taken significant steps to ensure there would be no repetition.
“He has a small, but strong, network of people around him who appear to genuinely care about him and support him. He has worked hard at maintaining his skills and knowledge, in so far as he has been able to in light of not being able to practise as a veterinary surgeon.
“He is thoughtful and realistic about his prospects going forward. His responses to questions about addiction were appropriate and persuasive. He has expressed genuine remorse and there is, in the Committee’s view, a public interest in allowing him to be restored to the Register.”
For the research, Miele commissioned independent market research firm Sapio to interview 1000 pet owners and 100 UK-based vet practices.
Veterinary practices have good reason to worry about complaints: the research showed that 89% of veterinary clients would be quick to tell others if they were dissatisfied with any aspect of the practice or care received. 63% said they would air their grievances on an online review site and 60% said they'd share their views on social media.
Those figures appear to be borne out by the fact that only 10% of vets said they had not seen any negative comments online about their practice.
Interviews with pet owners also found that the top five factors to affect a practice's reputation were: standard of care, a clean and hygienic environment, good customer service, the cost of treatment and waiting times, in that order.
64% of vets agreed that practice hygiene has become increasingly important with cleanliness of staff uniforms and waiting rooms among the first things that customers notice.
The suitably spruce Sam Bailey (pictured right), Sales & Marketing Director for the Professional division of Miele said: "Vet practices are increasingly coming under the same online scrutiny as hotels and restaurants and are being judged on everything from customer service through to staff appearance and waiting times.
"As our research results show, vets are already concerned about their reputations and it’s not just customer service and care outcomes that matter to pet owners, they also have high expectations when it comes to the practice environment too and are looking at cleanliness, hygiene and staff appearance.
"Through our network of approved partners we are working with more and more vet practices throughout the UK to ensure their on premise laundries not only meet WRAS regulations but also support their standards on hygiene, infection control and cleanliness."
With fewer than 72 female Suffolk Punches remaining in the UK and fewer than 300 in the world, every female born is vital to the survival of this endangered British horse.
In 2019 Tullis Matson, owner and managing director of Stallion AI Services, saw an opportunity to use a new technological advancement in the sex sorting of equine semen to provide a lifeline to Britain’s critically endangered rare and native horses.
Tullis said: “To be able to use our reproduction expertise in this way, to help preserve an irreplaceable part of our magnificent heavy horse heritage is something we have been working towards for many years. The challenges have been great and many, but watching the birth of this beautiful, healthy filly foal was a truly magical experience."
The sex sorting project uses specialist equipment to sex sort the semen prior to insemination based on the difference in DNA content between X and Y bearing spermatozoa.
Ruby, the Suffolk Punch mare and Holbeach Iggy, the Suffolk stallion were selected and matched based on their genetics as part of a project between The Rare Breed Survival Trust and Nottingham Trent University that uses pedigree information to enable the breeding of small populations in a way that minimises the risk of inbreeding and genetic decline.
Christopher Price, Chief Executive of the Rare Breed Survival Trust, said: “This is tremendous news for anyone concerned with the conservation of our native equines. The most effective way of increasing the population size of this very rare breed is by increasing the number of fillies being born.
“The project demonstrates the viability of using new techniques for selecting female foals in order to increase the breeding population much more rapidly than could be achieved through relying on traditional methods. We hope it will prove to be a model for more projects in the future.”
VETNAPP offers a replacement to paper records and allows entry of drugs administered, physiological parameters (for example heart rate, respiratory rate and blood pressure) and complications occurring during an anaesthetic. The final anaesthetic chart can be converted to a PDF and attached to patient records.
Alastair said: "My motivation for creating the app was born of my frustration while working in Australia about how many handwritten anaesthetic records were incomplete and poorly filled in.
"I developed the app in partnership with an IT graduate at the University of Sydney. It is a replacement for paper records, with features such as you cannot move on to the next page until all data fields are complete. It also allows storage of thousands of records, therefore, allows easy retrieval of records, and prevents lost records which is common with paper records.
"I also would like to eventually have a cloud-based storage of data to allow anaesthesia studies such as drugs used, morbidity/mortality studies, to be carried out on a large scale basis, rather than single centre studies."
VETNAPP has been designed to meet the needs of both general practitioner veterinary surgeons and veterinary specialists in anaesthesia and analgesia.
At present, VETNAPP is only available for the iPad, priced at £59.99.
To download VETNAPP, go to: https://itunes.apple.com/gb/app/vetnapp/id980918731?mt=8.
Mr Ghinescu faced three charges:
Mr Ghinescu admitted the facts of charges 1 and 2 but denied that this rendered him unfit to practise as a veterinary surgeon, although Dr Ghinescu has had the status of a non-practising Member of the RCVS since May 2021.
Regarding Charge 3, Mr Ghinescu said that the failure to declare the conviction had been a genuine misunderstanding about whether he needed to declare a driving conviction as part of his annual renewal.
The Committee found that while his position was ‘plainly unreasonable of him and wrong’, it could not be sure beyond all reasonable doubt that his mistaken beliefs were genuine or not – therefore it found it not proven that he had been dishonest.
Nevertheless, it found that Mr Ghinescu had been misleading by failing to declare his convictions, even if unintentionally.
Having found Charges 1, 2 and part of Charge 3 proven, the Committee considered Mr Ghinescu’s fitness to practise, taking into account the part of the Code of Professional Conduct that says veterinary surgeons ‘must not engage in any activity or behaviour that would be likely to bring the profession into disrepute or undermine public confidence in the profession.’
It found that the convictions outlined in Charges 1 and 2 rendered him unfit to practise as a veterinary surgeon and that whilst Charge 3 demonstrated carelessness, it did not amount to serious professional misconduct.
Mitigating factors included having had no previous disciplinary history with the RCVS, admissions at both court and to the College and developing insight into his behaviour, with an acceptance he had acted shamefully and had no mitigation for his behaviour.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee was of the view that the nature and seriousness of Mr Ghinescu’s behaviour, which led to the convictions, particularly the assault on his wife, was fundamentally incompatible with being registered as a veterinary surgeon.
"They are clearly serious offences as reflected in the prison sentence Mr Ghinescu was required to serve.
“There were two separate assaults on [his wife], one in the car and then a prolonged attack in the house, involving repeated punches to the face and kicks to the body, followed by threats to kill.
"The Committee considered this to be disgraceful conduct of the most grievous and reprehensible kind.
“The conduct represented a serious departure from professional standards; it was inexplicable, abhorrent behaviour, resulting in injuries to his wife.
"In light of these conclusions, the Committee decided that the only appropriate and proportionate sanction in this case was removal from the Register.”
Mr Ghinescu has 28 days from being informed of his removal from the Register to appeal the Committee’s decision.
For its research, the company surveyed 700 veterinary veterinary professionals.
The subsequent report, "Digital Adoption in Veterinary Medicine", provides up-to-date data on the levels of digital adoption by vets in the UK.
It also explores their attitudes to technology and digital communications tools, and the barriers to adoption. At the Zoom meeting, Scott Goodsir-Smyth, Provet Cloud’s VP of Growth for the UK & US will share and discuss some of the main findings of the report. He will also be answering questions about how practices can go digital, what the pitfalls are, how you can get the most value out of practice management software, and whether you should switch to the cloud. With the RCVS currently in the process of changing the rules regarding telemedicine, and only 23% of veterinary practices currently using telemedicine, this meeting could not be more timely. VetSurgeon.org and Provet are now inviting questions from vets about adopting digital technology, including online booking, integrated payments, pet owner apps, telemedicine, referral portals and digital whiteboards. The people who submit the best ten questions will be able to ask them before anyone else on the night and the best of the lot will get a bottle of champagne in time for Christmas.
To download the report, visit: https://www.provet.cloud/provet-cloud-digital-adoption-report To submit your question, email it to editor@vetsurgeon.org by Wednesday 9th November at 11:00am.
To register to join the Zoom meeting, visit: https://us06web.zoom.us/meeting/register/tZIsdOugpzMoGd0mrFcC_cyz1kNrGcwpMULV
Mr Gove ministerial statement followed the brouhaha last week when MP's voted against transferring the EU protocol on animal sentience into UK law.
However, Conservative MP Zac Goldsmith said in a tweet that the vote had not been about whether or not MPs recognise animals as sentient, but about the best legal framework within which to deliver high standards of animal welfare. Rachel Maclean, MP for Redditch also weighed in, saying that the idea that MPs had voted against animals as sentient beings was 'fake news'.
Mr Gove's ministerial statement reads as follows:
"This Government is committed to the very highest standards of animal welfare. As the Prime Minister has set out, we will make the United Kingdom a world leader in the care and protection of animals.
It has been suggested that the vote last week on New Clause 30 of the EU Withdrawal Bill somehow signalled a weakening in the protection of animals - that is wrong. Voting against the amendment was not a vote against the idea that animals are sentient and feel pain - that is a misconception.
Ministers explained on the floor of the house that this Government’s policies on animal welfare are driven by our recognition that animals are indeed sentient beings and we are acting energetically to reduce the risk of harm to animals – whether on farms or in the wild. The vote against New Clause 30 was the rejection of a faulty amendment, which would not have achieved its stated aims of providing appropriate protection for animals.
The Prime Minister has made clear that we will strengthen our animal welfare rules. This government will ensure that any necessary changes required to UK law are made in a rigorous and comprehensive way to ensure animal sentience is recognised after we leave the EU. The Withdrawal Bill is not the right place to address this, however we are considering the right legislative vehicle.
We are already proposing primary legislation to increase maximum sentences for animal cruelty from six months to five years, and the creation of a new statutory, independent body to uphold environmental standards.
The current EU instrument – Article 13 – has not delivered the progress we want to see. It does not have direct effect in law – in practice its effect is very unclear and it has failed to prevent practices across the EU which are cruel and painful to animals.
In contrast, here in the UK, we are improving animal welfare standards without EU input and beyond the scope of Article 13. We are making CCTV mandatory in all slaughterhouses – a requirement which goes above and beyond any EU rule. We will consult on draft legislation to jail animal abusers for up to five years – more than almost every other European nation. We propose combatting elephant poaching with a ban on the ivory trade which is more comprehensive than anywhere else in Europe. Our ban on microbeads which harm marine animals has been welcomed by Greenpeace as “the strongest in the world”, and is certainly the strongest in Europe.
Once we have left the EU there is even more we could do. EU rules prevent us from restricting or banning the live export of animals for slaughter. EU rules also restrict us from cracking down on puppy smuggling or banning the import of puppies under 6 months. Article 13 has not stopped any of these practices – but leaving the EU gives us the chance to do much better. We hope to say more in these areas next year.
This government will continue to promote and enhance animal welfare, both now and after we have left the EU."
Photo: Curious cattle on farmland in Cornwall UK. Shzphoto/Shutterstock
The 18,000 sq ft centre's facilities include a £1 million imaging suite with state-of-the-art MRI and CT scanners, five operating theatres and extensive kennelling facilities and cat wards. It is also equipped with fluoroscopy equipment with additional mobile C-arm, mobile digital radiography, a Phaco machine and Mindray WATO anaesthetic equipment.
A total of up to 80 staff will be employed at Paragon, including up to 18 referral veterinary surgeons and 32 nurses. Treatment will include ophthalmology, orthopaedics, soft tissue surgery, cardiology, neurology, medicine, oncology and dermatology.
The centre, which is part of Dewsbury-based Calder Vets, which has 12 practices across Yorkshire, is being led by managing director Ian Monteith and clinical director Adam Bell.
Adam said: "The opening of Paragon is the culmination of an 18-month project to bring the very best quality referral veterinary centre here to Wakefield.
"We’re delighted to open our doors and the team here at Paragon Veterinary Referrals are totally committed to, and looking forward to, providing excellent care for patients using the latest veterinary techniques."
For more information about the services Paragon will be offering, and for details of the vacancies on offer at the vet centre, as well as Continuing Professional Development (CPD) opportunities, visit www.paragonreferrals.co.uk.
The Vital Support launch includes a new Feline Renal Multipack to support cats with chronic kidney disease and loss of appetite. The multipack contains four wet pouches with different aromatic profiles to help stimulate decreased appetite and deliver optimum food acceptance and compliance. Multipacks will be available from October 2020.
Royal Canin has also introduced new Early Renal diets to help support the kidneys at early stages of renal insufficiency, and will be discontinuing its Feline VCN Senior Consult Stage 2 diets.
The company is also introducing two new diets for small dogs: Renal Small Dogs to support small breed dogs in the more advanced stages of chronic renal insufficiency, and Mobility C2P+ Small Dogs, formulated to support healthy joint function.
Other changes include a switch to 100% sustainably sourced salmon in its renal wet pouches, and to vegetable sources of glucosamine, instead of shellfish.
For more information, visit: https://vetportal.royalcanin.co.uk, speak to a member of the veterinary pillar team or contact the Nutritional Helpline.
Bonqat 50 mg/ml oral solution for cats contains pregabalin, an analgesic, anti-epileptic which has now been licensed for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.
Tessie 0.3 mg/ml oral solution for dogs contains tasipimidine and is licensed for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.
Dômes Pharma points to research which shows that in the UK 1.4 million1 dogs show signs of distress when left alone, and 4.4 million dogs1 show fear of loud noises.
In addition, over 4 million cats2 are not having routine vet checkups each year, with 26%2 of these owners reporting that it is too stressful for their cat or themselves.
Jonathan Hill, UK country manager at Dômes Pharma sid: "Dômes Pharma is excited to be launching two new innovative products to help vets manage cases in this complex area.
"These products expand our portfolio and provide essential options for owners and their pets struggling with these situational related problems."
https://www.tvm-uk.com/the-behavioural-range
Reference
Henry Schein, Inc. has announced the acquisition of Veterinary Instrumentation, the supplier of surgical instruments and implants to veterinary surgeons in the United Kingdom.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein said: "We are delighted to welcome this highly regarded company to the Henry Schein family, and very pleased that founder John Lapish and Managing Director Steve Fletcher will continue to drive the business forward.
"The success of Veterinary Instrumentation closely parallels the cornerstones of Henry Schein, including a deep understanding of customer needs, innovative solutions, superior product quality and customer service, and a trusted advisory relationship with our customers. Reinforcing our existing animal health business in the U.K., we look forward to strengthening our relationship with veterinary customers in this region, and bringing the Veterinary Instrumentation product portfolio of high-quality surgical specialties to a growing number of veterinarians across Europe, the United States and Australasia."
Veterinary Instrumentation was founded by John Lapish in 1986 in Sheffield, England, where the business and distribution operations are currently conducted from a single facility. Working as a small animal orthopaedic surgeon in the late 1970s, Mr. Lapish began designing and developing a range of instruments specifically for veterinary surgery, initially for his own use. As requests for these products increased, the market need became clear and Veterinary Instrumentation was formed, in particular to meet the needs of orthopaedic surgeons focused on small animals.
Mr Lapish said: "We look forward to contributing to the continued growth and success of a leading supplier of companion animal health products and services in the United Kingdom and to becoming part of a global leader in the distribution of health care products and services.
"The expertise that we bring in the area of veterinary surgical instruments will complement Henry Schein's broad offering, and our customers will benefit greatly from the global resources of a company that has quickly become an animal health care product and service leader on three continents."
With approximately 60 percent of sales in the U.K., and the balance split fairly evenly between Europe and the rest of the world, Veterinary Instrumentation has 20 employees, including a team of eight Veterinary Technicians who advise customers on the most appropriate procedures and instrumentation.
Veterinary Instrumentation sales for the 12 months ended September 30, 2011 were approximately £6.7 million ($10.8 million). Financial terms of the transaction were not disclosed.
According to a report in the Daily Mail, Worcester vet David Denny MRCVS accidentally euthanised a Jack Russell in the presence of its owner, who believed he was giving the animal antibiotics.
Mr Denny told VetSurgeon.org that it had been the result of a dreadful misunderstanding between himself and his secretary, for which he had apologised, but that he couldn't say much more because the VDS had advised him not to talk to the media.
The dog, called Gunner, was 14 years old; old enough that alarm bells obviously didn't go off when it was presented to Mr Denny for euthanasia (or so he thought).
The story does serve as a reminder of the importance of communicating with absolute clarity, both written and oral, when performing euthanasia. In this case, the Daily Mail reports that Mr Denny asked the client: "if Gunner had had enough". Under any other circumstances, that would seem a sensitive comment to make. In this case, though, the owner thought he meant the dog had had enough of its cough.
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
The company says the new product has been launched in response to demand from UK equine veterinary surgeons specialising in dentistry
Hexarinse for Horses is presented as a palatable, mint-flavoured, ready-to-use formulation in a five litre container.
Virbac says the antibacterial action of chlorhexidine supports the maintenance of oral health after dental procedures and may aid the management of periodontal disease, oral inflammation and the management of peripheral caries.
For further information, speak to your local Virbac territory manager or contact Virbac Limited on: 01359 243243 or enquiries@virbac.co.uk.
The study1, which was conducted by surgery resident Dr Charlie Brincin at Highcroft Veterinary Group (soon to be Bristol Vet Specialists) and orthopaedic surgeon Dr Matt Matiasovic at Manchester Vet Specialists, looked at the records of 825 dogs that had been treated surgically for unilateral MPL at 10 referral centres, and then had a planned follow-up visit, including radiographs.
The frequency of, and reasons for, changes in further recovery recommendations were investigated.
The findings demonstrated that if the dog made an uneventful2 recovery after surgery, was presented without owner concern, and if no abnormality was found on physical examination, then radiographic findings only led to a change in recommendation in 3% (13/432) of these dogs.
Researchers say that this reflects similar research on the influence of follow-up radiographs in human medicine, and those of previous veterinary studies on post-operative radiographs, following uncomplicated tibial plateau leveling osteotomy (TPLO). These particular studies3,4 showed radiography had an impact on post-operative management in just 2%-3.8% of cases.
As a result of the MPL and TPLO studies, Highcroft Veterinary Referrals and Manchester Veterinary Specialists will no longer systematically perform follow-up radiographs on their patients, unless justified clinically.
Charlie said: “Radiographs are not without additional costs or risks - including radiation exposure, sedation-associated risks and strain on veterinary staff.
"Radiographic intervention should be clinically justified and our study suggests that if the dog had an uneventful recovery and is presented without owner or clinician raised concern, then repeat radiographs might not be necessary.
"This study also highlights the value of a thorough owner history and clinical examination for clinical decision-making when re-examining dogs following this orthopaedic surgery.”
The MPL study also evaluated factors which significantly increased the risk of finding radiographic abnormalities at routine follow-up, and those which led to a change in post-operative recommendation.
Lameness, administration of analgesia at follow-up, and history of unplanned visits prior to routine re-examination were associated with increased odds of a change in postoperative plan (P < 0.001).
In the absence of owner and clinician concerns, the odds of having a change in convalescence plans were not different, whether or not isolated radiographic abnormalities were present (P = 0.641).
The main aim of the campaign is to persuade anyone thinking of getting a puppy that they should always see the animal at least once whilst it is still dependent on its mother, before they buy. That way, they'll be able to reassure themselves that they have seen the real bitch and the environment in which the puppy was bred. It will also help prevent impulse purchases.
In addition, the campaign aims to raise awareness in the veterinary profession, so that veterinary surgeons are giving this same advice to their clients.
To that end, the campaign highlights the RSPCA 'Sold a pup' report which showed that over 400,000 pups are bred for the UK market each year by unlicensed establishments, and imports from Europe have increased to an estimated 30,000 in 2015, following the change in the PETS scheme in 2012.
The campaigners say that many of these puppies are bred in truly awful conditions, often with little or no human contact, before being taken taken from their mothers too early and transported often hundreds or thousands of miles to be sold as 'family' pets. Many will need veterinary care to deal with infections, inherited issues and behavioural problems.
The campaign faces a big challenge. In the Kennel Club PAW survey 2014, 41% of people who bought a puppy didn't see the bitch and 51% didn't see the environment where the litter was bred.
To spread the word, veterinary surgeons, veterinary nurses and pet owners are being asked to take a pouting selfie with their dog and post it on social networks like Facebook, with the hashtags #PoutForPuppies #SeeThemSuckling, linking to the campaign website: https://seethemsuckling.com
Andrew Montgomery, veterinary adviser for MSD Animal Health, says this is a very positive outcome for the industry: "It is estimated that 90% of UK herds have been exposed to bovine viral diarrhoea1 (BVD), costing the UK cattle industry up to £61 million each year2."
The new Summary of Product Characteristics for Bovilis BVD states that following primary immunisation, consisting of two vaccinations given 4 weeks apart to cattle over the age of 8 months, and a further vaccination 6 months after this, revaccinations can be given at up to 12 month intervals.
Andrew said: "The fundamental principle of control, is to identify and remove persistently infected (PI) animals from a herd, and stop PIs being created using a trusted and proven vaccine.
"Providing primary immunisation has been finalised 4 weeks before the start of gestation, Bovilis BVD is licensed to protect the foetus against transplacental infection, preventing the creation of a PI calf which is hugely significant for BVD control.
"The convenience of being able to vaccinate on a herd level without having to assess pregnant animals on a case-by-case basis provides the flexibility to tailor vaccination schedules to the farm system, which for many vets and farmers comes as a convenient solution."
MSD says Bovilis BVD also has the advantage of not interfering with antigen ELISA or PCR testing and can be jointly administered with other routine vaccines.
For example, Bovilis BVD can be mixed and administered with Bovilis® IBR Marker Live when given as a booster dose to cattle from 15 months of age, or can be administered on the same day as Leptavoid-H in cattle from 8 months of age.
For further information, refer to the product data sheets at www.noahcompendium.co.uk and SPCs and/or speak to your local MSD Animal Health area manager.